New corporate identity reflects Company’s strategic evolution into a diversified cannabinoid health sciences platform (Form 8-K)

New corporate identity reflects Company's strategic evolution into a diversified cannabinoid health sciences platform

FORT LAUDERDALE, Fla., August 12, 2026 - Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company") today announced its intention to change its corporate name to Endovia Health Sciences, Inc., effective August 24, 2026. At that time, the Company will also adopt a new ticker symbol of "EDVA" and launch EndoviaSciences.com in connection with the rebranding.

The name change reflects the Company's strategic transformation from a legacy beverage business into a diversified cannabinoid health sciences platform focused on commercializing pharmaceutical assets, advancing FDA-regulated human and veterinary therapeutics, and developing innovative cannabinoid wellness and beverage products.

"This is much more than a name change-it is the culmination of a deliberate strategic transformation," said Brady Cobb, Interim Chief Executive Officer of the Company.

"Over the past six (6) months, we have methodically repositioned the Company by acquiring differentiated pharmaceutical intellectual property, establishing international commercialization opportunities, expanding into FDA-regulated veterinary therapeutics and assembling an experienced cannabinoid pharmaceutical development team. Endovia Health Sciences reflects both who we are today and the company we intend to become."

Building a Diversified Cannabinoid Health Sciences Platform

Endovia Health Sciences is being built around three complementary growth engines designed to create multiple avenues for long-term growth and shareholder value.

Commercial Pharmaceutical Assets

Commercializing differentiated cannabinoid pharmaceutical products through international distribution, strategic partnerships and licensing opportunities.

FDA-Regulated Human & Veterinary Therapeutics

Advancing proprietary cannabinoid medicines through established regulatory pathways for both human and companion-animal health.

Consumer Wellness & Beverages

Developing innovative cannabinoid wellness products and beverages as regulations continue to evolve and new markets emerge.

The Company believes this diversified strategy provides a capital-efficient approach to building long-term enterprise value while leveraging a common foundation of cannabinoid science, intellectual property and commercial execution.

Our Vision

To become the global leader in cannabinoid health sciences by developing, commercializing and advancing innovative therapies and wellness solutions that improve the lives of people and animals around the world.

Our Mission

Endovia Health Sciences acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Through disciplined capital allocation, scientific excellence and strategic partnerships, we build scalable businesses that deliver meaningful healthcare innovation and long-term shareholder value.

"We believe cannabinoids represent one of the most promising frontiers in modern health sciences," Cobb continued.

"Our mission is to responsibly unlock that potential through scientific innovation, strategic partnerships and disciplined execution. Every acquisition, every partnership and every investment we make is intended to strengthen our position as a leading cannabinoid health sciences company and create lasting value for patients, consumers, partners and shareholders."

Looking Ahead

The Company expects the Endovia rebrand to coincide with the launch of a new corporate website, refreshed investor materials and a unified corporate identity designed to reflect its long-term strategic vision.

As Endovia Health Sciences, the Company intends to continue expanding its portfolio through strategic acquisitions, commercial partnerships, regulated pharmaceutical development and innovative consumer health products, all centered on advancing cannabinoid science through disciplined execution.

"Our focus is clear," Cobb concluded. "Build a science-driven company with differentiated intellectual property, experienced leadership and multiple pathways to sustainable growth. We believe Endovia Health Sciences represents the beginning of an exciting new chapter for our shareholders, our partners and the patients and consumers we ultimately serve."

About Endovia Health Sciences (Proposed)

Endovia Health Sciences is building a diversified cannabinoid health sciences platform focused on acquiring, developing and commercializing differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets.

Where Science Meets Cannabinoid Innovation